$RAFA Rafarma Pharmaceuticals is positioned to capitalize and grow from two significant variables saddling the Eastern European Pharmaceuticals market: growing demand and a struggling economy. The population of elderly citizens throughout Eastern Europe has grown alongside the region’s economic hardship.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.